Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Bioqual (BIOQ) Stock Price & Analysis

19 Followers

BIOQ Stock Chart & Stats

$30.25$0.00(0.00%)
At close: 4:00 PM EST
$31$32$33Aug 31Oct 21Oct 28
Day’s Range
$30.00 - $30.50
52-Week Range
$30.00 - $40.00
Previous Close
$30.25
Volume
N/A
Average Volume (3M)
33
Market Cap
$27.04M
Enterprise Value
$44.97M
Total Cash (Recent Filing)
$16.47M
Total Debt (Recent Filing)
$31.92M
Price to Earnings (P/E)
―
Beta
-0.18
Next Earnings
Jan 15, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Oct 07, 2024
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Rebound

The sharp TTM revenue rebound indicates renewed demand for BIOQ’s services and provides a larger base from which operating performance can recover. If sustained, stronger sales should improve utilization, support investment in capabilities, and reinforce customer relationships over the coming quarters.

Specialized Service Platform

BIOQ operates in specialized infectious-disease and immunology testing, where technical capabilities and study-support experience can support customer retention. Its services address pharmaceutical, biotechnology, government, and academic users, giving the platform relevance across several research markets.

Prior Profitability

BIOQ’s profitability in 2022–2024 demonstrates that the business has previously converted its service activity into earnings and maintained healthier margins. That track record provides evidence of potential earnings capacity if revenue recovery is accompanied by improved cost control and operating efficiency.

Bears Say

Persistent Losses

The return to sizable losses shows that current revenue levels are not producing adequate earnings after costs. Continued negative margins can erode equity, restrict reinvestment, and make future performance dependent on a successful improvement in pricing, mix, or operating efficiency.

Negative Cash Generation

Negative operating and free cash flow indicate that reported business activity is not currently funding ongoing needs internally. This reduces flexibility to invest in capabilities or absorb weaker demand, while increasing the importance of restoring profitability and cash conversion.

Higher Leverage

Debt now approximates equity, representing a meaningful increase in leverage compared with earlier years. Higher financial obligations can magnify the impact of continued losses, constrain capital allocation, and increase reliance on financing while the company works to rebuild returns.

Bioqual News

BIOQ FAQ

What was Bioqual’s price range in the past 12 months?
Bioqual lowest stock price was $30.00 and its highest was $40.00 in the past 12 months.
What is Bioqual’s market cap?
Bioqual’s market cap is $27.04M.
When is Bioqual’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bioqual’s earnings last quarter?
Bioqual released its earnings results on Sep 18, 2026. The company reported -$0.553 earnings per share for the quarter.
Is Bioqual overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Bioqual pay dividends?
Bioqual pays an annual dividend of $0.5 which represents an annual dividend yield of ―. See more information on Bioqual dividends here
What is Bioqual’s EPS estimate?
Bioqual’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bioqual have?
Bioqual has 893,838 shares outstanding.
What happened to Bioqual’s price movement after its last earnings report?
Bioqual reported an EPS of -$0.553 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Bioqual?
Currently, no hedge funds are holding shares in BIOQ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology